Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Bortezomib + Pembrolizumab/Cisplatin for Metastatic Breast Cancer
Recruiting3 awardsPhase < 1
Dallas, Texas
This trial is testing whether a drug called bortezomib can help treat a type of breast cancer that has spread to other parts of the body. The trial will look at the cancer cells before and after treatment to see how well the drug works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service